Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson's Disease
Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...
GlobalData on MSN1d
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Researchers identify a potential biomarker of Parkinson's disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
News Medical on MSN16h
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Jewish Press1d
TAU Researchers Discover Potential Target for Effective Parkinson’s Treatments
Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...
Armed robbery in Revesby1d
Biomarker Found for Parkinson's Disease Progression
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
WESA2d
Pitt to advance research into improving mobility for Parkinson’s patients
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
The Pharma Letter2d
Growing emphasis on disease-modifying therapies in Parkinson’s
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...
Major discovery in the treatment of Parkinson's and Alzheimer's disease: This study says transplanting brain cells could be revolutionary to cure neurological disorders
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
clinicaltrialsarena5d
Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents
Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...
Healthcare Asia on MSN1d
7MM Parkinson’s disease pipeline focuses on disease-modifying agents
There are a total of 93 products in Phase I-III development for PD treatment. The Parkinson’s disease (PD) therapeutic ...
Science Daily3d
Parkinson's Research News
Aug. 19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's ...